about
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonistThe role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome XImidazoleacetic acid-ribotide: An endogenous ligand that stimulates imidazol(in)e receptorsImidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization.Reproducible MRI measurement of adipose tissue volumes in genetic and dietary rodent obesity models.H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.The I(1)-imidazoline receptor in PC12 pheochromocytoma cells reverses NGF-induced ERK activation and induces MKP-2 phosphatase.Pharmacology of moxonidine: an I1-imidazoline receptor agonist.IRAS splice variants.High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets.Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?Pharmacological properties of the central antihypertensive agent, moxonidine.Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells.Quantitative distribution of muscarinic receptors and choline acetyltransferase in rat medulla: examination of transmitter-receptor mismatch.Open-field behavior in two models of genetic hypertension and the behavioral effects of salt excess.L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists.The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity.Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.Contrasting metabolic effects of antihypertensive agents.The epidemiology of overweight and obesity: public health crisis or moral panic?Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice.Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.The National Weight Control Registry: a critique.Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin.Effects of weight cycling on urinary catecholamines: sympathoadrenal role in refeeding hypertension.A high density of muscarinic receptors in the rostral ventrolateral medulla of the rat is revealed by correction for autoradiographic efficiency.An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla.A specific antiserum recognizes clonidine-displacing substance: implications for the structure of the brain's own clonidine.Moxonidine acting centrally inhibits airway reflex responses.Imidazoline receptor antisera-selected cDNA clone and mRNA distribution.A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.Clonidine displacing substance is biologically active on smooth muscle.Intramedullary sodium cyanide injection on respiratory and vasomotor responses in cats.Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB).Para-azidoclonidine: a novel photoaffinity ligand for the alpha 2-receptor.An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.
P50
Q24535736-7E25B32C-BFC7-42BB-9F4D-3D9D719DAB78Q28579750-24F97524-2499-4007-ADAF-B3A9D3D400F7Q30048258-6118DC15-443B-4924-A8B4-55154804F757Q30883991-2CB0D3EA-72CF-4D1C-A11F-80F7083E585EQ33372404-AEECC22D-213C-477B-8079-A106F14BA9C3Q33964839-F48F1AEF-84ED-4456-A903-A25E3B36544CQ34095495-4FF077AF-FFB1-4E2E-81CF-68F4ACD26FEFQ34214611-BA6F4C73-B94E-444C-9407-A39B90141447Q34247478-B799B781-1695-4BE6-89FA-7DE87AB5B24CQ34306745-C370FAE7-0DCA-44E1-9D0D-8B9D6F813F59Q35012934-0781B81D-0591-4128-A90C-D8774A59EF60Q36736724-0CC30EC7-9B46-49D4-934D-38D2396A1C1BQ37925014-E04DA125-ACF1-4D83-90E1-EF06EFA2F3A7Q38305408-326FCD01-6C07-4A14-81E1-E49E8CB097C4Q41439986-C767CF0B-0065-4FA5-9221-7707D46A9E1CQ43324369-0AF800CC-11F2-4AA3-80A0-C46897246EE0Q44370393-AC9CCC90-9D22-44D8-BE80-0EA5398E8128Q44447221-30B5FC71-5800-455F-81FC-2EFB0D3B8BECQ44493282-CBB2BC5A-92FD-4E32-BDE0-94CCCA85D16CQ44588327-64FF0E3D-0902-4D79-B2C3-F36BFCBB043DQ44616406-6B33DFA4-AE79-4308-85A7-CCBF5F8F6142Q44947045-A5F24A13-C115-4983-A6B7-892A8058A543Q45304589-040CFE7B-C0BF-4B56-B0ED-EF23F550CFD1Q46251819-09EAF41C-8DAB-4722-9E3D-3D2030DFE7C0Q46440344-2EEC1D79-3022-4CD7-B1DF-BDB38FE603E1Q46747466-4D3D37B5-0856-41FC-90DD-CFA70A2E1FC3Q46896444-E4D3FCC7-7E4F-4344-896B-A3EA14BB2FB8Q46916971-2809FD55-F002-45D9-AD74-CF0F3FB3E42BQ47272999-85C111F9-59B7-41C8-B61A-324DCCF48FF6Q48110265-E6AA03C2-F8BB-468F-A051-C32AA8DB0322Q48111434-4D0AB13D-3EE6-46C4-A174-86E45D9CE76AQ48123764-56F47FA3-B5EA-47BA-A8F2-114DA6A0DBDFQ48155070-791F895C-B320-410D-8EF9-9F3933AAEB5FQ48155303-AC8BFCAF-7346-4959-B647-18EC848D850EQ48165359-EB512F73-EB56-4938-B6AC-53EE51CCE5F2Q48193011-270EFF13-5BAB-48DA-B4BA-2FF66120CFBEQ48255103-66EB5D29-AACB-4073-9270-A4DB1B659FDBQ48320575-C755B66D-5381-4ECF-9714-14C224FC74C7Q48353519-65469AF6-5F79-4AAA-84E6-9630B4C02D71Q48365487-D76A5EF9-CC26-49A2-81F4-FE2DD97B08BC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paul Ernsberger
@ast
Paul Ernsberger
@en
Paul Ernsberger
@es
Paul Ernsberger
@nl
Paul Ernsberger
@sl
type
label
Paul Ernsberger
@ast
Paul Ernsberger
@en
Paul Ernsberger
@es
Paul Ernsberger
@nl
Paul Ernsberger
@sl
prefLabel
Paul Ernsberger
@ast
Paul Ernsberger
@en
Paul Ernsberger
@es
Paul Ernsberger
@nl
Paul Ernsberger
@sl
P1053
O-2702-2014
P106
P21
P2798
P31
P3829
P496
0000-0003-2372-2500